Selected research
Industry Research
Human Fibrinogen Concentrate Industry Research Report 2026
Market perspective
The global Human Fibrinogen Concentrate market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Human Fibrinogen Concentrate is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Human Fibrinogen Concentrate is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Human Fibrinogen Concentrate is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Human Fibrinogen Concentrate include Shanghai XinXing Medical, Shanghai RAAS, Hualan Biological Engineering, Harbin Pacific Biopharmaceutical, LFB Group, Greencross, CSL Behring and Boya, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Human Fibrinogen Concentrate market in terms of revenue (US$ million) and, where applicable, sales volume (k tons), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k tons) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Human Fibrinogen Concentrate Market by Company
Shanghai XinXing Medical
Shanghai RAAS
Hualan Biological Engineering
Harbin Pacific Biopharmaceutical
LFB Group
Greencross
CSL Behring
Boya
Human Fibrinogen Concentrate Segment by Type
0.5g
1.0g
Human Fibrinogen Concentrate Segment by Application
Congenital Fibrinogen Deficiency
Surgical Procedures
Human Fibrinogen Concentrate Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Fibrinogen Concentrate market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Human Fibrinogen Concentrate and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human Fibrinogen Concentrate.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Human Fibrinogen Concentrate manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Human Fibrinogen Concentrate by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Human Fibrinogen Concentrate in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 0.5g
- 1.0g
Applications
- Congenital Fibrinogen Deficiency
- Surgical Procedures
Companies covered
- Shanghai XinXing Medical
- Shanghai RAAS
- Hualan Biological Engineering
- Harbin Pacific Biopharmaceutical
- LFB Group
- Greencross
- CSL Behring
- Boya
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Human Fibrinogen Concentrate Market Size (2021-2032)
- 2.2.2 Global Human Fibrinogen Concentrate Sales (2021-2032)
- 2.2.3 Global Human Fibrinogen Concentrate Market Average Price (2021-2032)
- 2.3 Human Fibrinogen Concentrate by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 0.5g
- 2.3.3 1.0g
- 2.4 Human Fibrinogen Concentrate by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Congenital Fibrinogen Deficiency
- 2.4.3 Surgical Procedures
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Human Fibrinogen Concentrate Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Human Fibrinogen Concentrate Sales (k tons) of Manufacturers (2021-2026)
- 3.3 Global Human Fibrinogen Concentrate Revenue of Manufacturers (2021-2026)
- 3.4 Global Human Fibrinogen Concentrate Average Price by Manufacturers (2021-2026)
- 3.5 Global Human Fibrinogen Concentrate Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Human Fibrinogen Concentrate, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Human Fibrinogen Concentrate, Product Type & Application
- 3.8 Global Manufacturers of Human Fibrinogen Concentrate, Established Date
- 3.9 Global Human Fibrinogen Concentrate Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Shanghai XinXing Medical
- 4.1.1 Shanghai XinXing Medical Company Information
- 4.1.2 Shanghai XinXing Medical Business Overview
- 4.1.3 Shanghai XinXing Medical Human Fibrinogen Concentrate Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Shanghai XinXing Medical Human Fibrinogen Concentrate Product Portfolio
- 4.1.5 Shanghai XinXing Medical Recent Developments
- 4.2 Shanghai RAAS
- 4.2.1 Shanghai RAAS Company Information
- 4.2.2 Shanghai RAAS Business Overview
- 4.2.3 Shanghai RAAS Human Fibrinogen Concentrate Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Shanghai RAAS Human Fibrinogen Concentrate Product Portfolio
- 4.2.5 Shanghai RAAS Recent Developments
- 4.3 Hualan Biological Engineering
- 4.3.1 Hualan Biological Engineering Company Information
- 4.3.2 Hualan Biological Engineering Business Overview
- 4.3.3 Hualan Biological Engineering Human Fibrinogen Concentrate Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Hualan Biological Engineering Human Fibrinogen Concentrate Product Portfolio
- 4.3.5 Hualan Biological Engineering Recent Developments
- 4.4 Harbin Pacific Biopharmaceutical
- 4.4.1 Harbin Pacific Biopharmaceutical Company Information
- 4.4.2 Harbin Pacific Biopharmaceutical Business Overview
- 4.4.3 Harbin Pacific Biopharmaceutical Human Fibrinogen Concentrate Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Harbin Pacific Biopharmaceutical Human Fibrinogen Concentrate Product Portfolio
- 4.4.5 Harbin Pacific Biopharmaceutical Recent Developments
- 4.5 LFB Group
- 4.5.1 LFB Group Company Information
- 4.5.2 LFB Group Business Overview
- 4.5.3 LFB Group Human Fibrinogen Concentrate Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 LFB Group Human Fibrinogen Concentrate Product Portfolio
- 4.5.5 LFB Group Recent Developments
- 4.6 Greencross
- 4.6.1 Greencross Company Information
- 4.6.2 Greencross Business Overview
- 4.6.3 Greencross Human Fibrinogen Concentrate Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Greencross Human Fibrinogen Concentrate Product Portfolio
- 4.6.5 Greencross Recent Developments
- 4.7 CSL Behring
- 4.7.1 CSL Behring Company Information
- 4.7.2 CSL Behring Business Overview
- 4.7.3 CSL Behring Human Fibrinogen Concentrate Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 CSL Behring Human Fibrinogen Concentrate Product Portfolio
- 4.7.5 CSL Behring Recent Developments
- 4.8 Boya
- 4.8.1 Boya Company Information
- 4.8.2 Boya Business Overview
- 4.8.3 Boya Human Fibrinogen Concentrate Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Boya Human Fibrinogen Concentrate Product Portfolio
- 4.8.5 Boya Recent Developments
5 Global Human Fibrinogen Concentrate Market Scenario by Region
- 5.1 Global Human Fibrinogen Concentrate Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Human Fibrinogen Concentrate Sales by Region: 2021-2032
- 5.2.1 Global Human Fibrinogen Concentrate Sales by Region: 2021-2026
- 5.2.2 Global Human Fibrinogen Concentrate Sales by Region: 2027-2032
- 5.3 Global Human Fibrinogen Concentrate Revenue by Region: 2021-2032
- 5.3.1 Global Human Fibrinogen Concentrate Revenue by Region: 2021-2026
- 5.3.2 Global Human Fibrinogen Concentrate Revenue by Region: 2027-2032
- 5.4 North America Human Fibrinogen Concentrate Market Facts & Figures by Country
- 5.4.1 North America Human Fibrinogen Concentrate Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Human Fibrinogen Concentrate Sales by Country (2021-2032)
- 5.4.3 North America Human Fibrinogen Concentrate Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Human Fibrinogen Concentrate Market Facts & Figures by Country
- 5.5.1 Europe Human Fibrinogen Concentrate Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Human Fibrinogen Concentrate Sales by Country (2021-2032)
- 5.5.3 Europe Human Fibrinogen Concentrate Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Human Fibrinogen Concentrate Market Facts & Figures by Country
- 5.6.1 Asia Pacific Human Fibrinogen Concentrate Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Human Fibrinogen Concentrate Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Human Fibrinogen Concentrate Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Human Fibrinogen Concentrate Market Facts & Figures by Country
- 5.7.1 South America Human Fibrinogen Concentrate Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Human Fibrinogen Concentrate Sales by Country (2021-2032)
- 5.7.3 South America Human Fibrinogen Concentrate Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Human Fibrinogen Concentrate Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Human Fibrinogen Concentrate Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Human Fibrinogen Concentrate Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Human Fibrinogen Concentrate Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Human Fibrinogen Concentrate Sales by Type (2021-2032)
- 6.1.1 Global Human Fibrinogen Concentrate Sales by Type (2021-2032) & (k tons)
- 6.1.2 Global Human Fibrinogen Concentrate Sales Market Share by Type (2021-2032)
- 6.2 Global Human Fibrinogen Concentrate Revenue by Type (2021-2032)
- 6.2.1 Global Human Fibrinogen Concentrate Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Human Fibrinogen Concentrate Revenue Market Share by Type (2021-2032)
- 6.3 Global Human Fibrinogen Concentrate Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Human Fibrinogen Concentrate Sales by Application (2021-2032)
- 7.1.1 Global Human Fibrinogen Concentrate Sales by Application (2021-2032) & (k tons)
- 7.1.2 Global Human Fibrinogen Concentrate Sales Market Share by Application (2021-2032)
- 7.2 Global Human Fibrinogen Concentrate Revenue by Application (2021-2032)
- 7.2.1 Global Human Fibrinogen Concentrate Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Human Fibrinogen Concentrate Revenue Market Share by Application (2021-2032)
- 7.3 Global Human Fibrinogen Concentrate Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Human Fibrinogen Concentrate Value Chain Analysis
- 8.1.1 Human Fibrinogen Concentrate Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Human Fibrinogen Concentrate Production Mode & Process
- 8.2 Human Fibrinogen Concentrate Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Human Fibrinogen Concentrate Distributors
- 8.2.3 Human Fibrinogen Concentrate Customers
9 Global Human Fibrinogen Concentrate Analyzing Market Dynamics
- 9.1 Human Fibrinogen Concentrate Industry Trends
- 9.2 Human Fibrinogen Concentrate Industry Drivers
- 9.3 Human Fibrinogen Concentrate Industry Opportunities and Challenges
- 9.4 Human Fibrinogen Concentrate Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst